Millennium Management
MDGL icon

Millennium Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Millennium Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,700
Closed -$525K – 6192
2024
Q4 		$525K Sell
1,700
-8,300
-83% -$2.33M ﹤0.01% 4713
2024
Q3 		$2.12M Buy
10,000
+2,500
+33% +$640K ﹤0.01% 3652
2024
Q2 		$2.1M Buy
+7,500
New +$1.79M ﹤0.01% 3501
2024
Q1 		– Sell
-10,400
Closed -$2.41M – 6460
2023
Q4 		$2.41M Sell
10,400
-2,900
-22% -$507K ﹤0.01% 3455
2023
Q3 		$1.94M Buy
+13,300
New +$2.5M ﹤0.01% 3580
2023
Q1 		– Sell
-24,800
Closed -$7.2M – 6653
2022
Q4 		$7.2M Buy
24,800
+21,400
+629% +$2.09M ﹤0.01% 2478
2022
Q3 		$221K Buy
+3,400
New +$236K ﹤0.01% 5591

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management's MDGL Position: Q1 2026 in Review

Millennium Management increased its Madrigal Pharmaceuticals (MDGL) stake by 485% in Q1 2026, buying an estimated $16.2M and bringing the position to 40,853 shares worth $21.4M. The position accounts for 0.01% of the portfolio, ranked #1493.

Millennium Management first reported a position in MDGL in Q2 2013 and has held it in 39 quarters since. The position peaked at $29.1M in Q1 2023. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Millennium Management held 40,853 shares of Madrigal Pharmaceuticals worth $21.4M as of Q1 2026.
  • Millennium Management bought 33,875 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $16.2M.
  • Madrigal Pharmaceuticals made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1493 holding.
  • Millennium Management first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 39 quarters since.
  • Millennium Management's Madrigal Pharmaceuticals position peaked at $29.1M in Q1 2023.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.